OncoTherapy Science (30O) Revenue
OncoTherapy Science Revenue
OncoTherapy Science had a revenue of 201.49M in the quarter ending Jun 30, 2024, with 7.89%. This bring the company's revenue in the last twelve months to 851.24M, Increased 13.54%. In the fiscal year ending Mar 31, 2026, OncoTherapy Science had annual revenue of 808.53M with 7.80% growth.
- Revenue (ttm)
- 851.24M
- Revenue Growth
- -17.22%
- P/S Ratio
- 0.05
- Revenue/Employee
- EUR 17,576,739
- Employees
- 46
- Market Cap
- EUR 41.68M
Revenue Chart
OncoTherapy Science Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 808.53M | 58.48M | 7.80% |
| Mar 31, 2025 | 750.05M | 139.93M | 22.93% |
| Mar 31, 2024 | 610.12M | -524.78M | -46.24% |
| Mar 31, 2022 | 1.13B | -18.76M | -1.63% |
| Mar 31, 2021 | 1.15B | 821.19M | 246.99% |
| Mar 31, 2021 | 332.48M | 16.26M | 5.14% |
| Mar 31, 2020 | 316.21M | 35.63M | 12.70% |
| Mar 31, 2019 | 280.59M | 69.33M | 32.82% |
| Mar 31, 2018 | 211.25M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.